Elemental Impurities in drug products can arise from several sources, including interactions with processing equipment or container/closure systems, presence in the components of the drug product, or even intentionally through residual catalysts added in synthesis. However they got there, the levels of impurities need to be controlled or they can have a negative impact on your final drug product.
In this webinar you will learn:
- How to take control of elemental impurities in drug products
- The principles of quality risk management described in ICH Q8 and Q9 guidelines
- How to make compliance turnkey